--- title: "China Renaissance Reaffirms Their Buy Rating on Meituan (MPNGF)" type: "News" locale: "en" url: "https://longbridge.com/en/news/281701303.md" description: "China Renaissance has reaffirmed a Buy rating on Meituan (MPNGF) with a price target of HK$120.00. This follows a similar Buy rating from CGS International's Lei Yang CFA on March 31. However, Barclays issued a Sell rating on Meituan on March 27." datetime: "2026-04-05T05:25:57.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/281701303.md) - [en](https://longbridge.com/en/news/281701303.md) - [zh-HK](https://longbridge.com/zh-HK/news/281701303.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/281701303.md) | [繁體中文](https://longbridge.com/zh-HK/news/281701303.md) # China Renaissance Reaffirms Their Buy Rating on Meituan (MPNGF) In a report released yesterday, from China Renaissance maintained a Buy rating on Meituan, with a price target of HK$120.00. ### End of Quarter Sale - 50% Off TipRanks - Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions - Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks In addition to China Renaissance, Meituan also received a Buy from CGS International’s Lei Yang CFA in a report issued on March 31. However, on March 27, Barclays maintained a Sell rating on Meituan (Other OTC: MPNGF). ### Related Stocks - [Meituan (MPNGY.US)](https://longbridge.com/en/quote/MPNGY.US.md) - [MEITUAN-W (03690.HK)](https://longbridge.com/en/quote/03690.HK.md) ## Related News & Research - [China regulator orders food delivery giants to strengthen safety controls](https://longbridge.com/en/news/281633054.md) - [CGS International Reaffirms Their Buy Rating on Grab (GRAB)](https://longbridge.com/en/news/281555540.md) - [Laopu Gold Co. Ltd. Class H (6181) Receives a Buy from CGS International](https://longbridge.com/en/news/281138022.md) - [BWX Technologies (BWXT) Has a New Rating from Wells Fargo](https://longbridge.com/en/news/281254095.md) - [Caleres’ Licensing Risk: Partner Performance, Brand Dilution, and Revenue Disruption Challenges](https://longbridge.com/en/news/281674788.md)